103 related articles for article (PubMed ID: 11425524)
1. Dibasic inhibitors of human mast cell tryptase. Part 3: identification of a series of potent and selective inhibitors containing the benzamidine functionality.
Dener JM; Rice KD; Newcomb WS; Wang VR; Young WB; Gangloff AR; Kuo EY; Cregar L; Putnam D; Wong M
Bioorg Med Chem Lett; 2001 Jul; 11(13):1629-33. PubMed ID: 11425524
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological activity of potent and selective inhibitors of mast cell tryptase.
Hopkins CR; Czekaj M; Kaye SS; Gao Z; Pribish J; Pauls H; Liang G; Sides K; Cramer D; Cairns J; Luo Y; Lim HK; Vaz R; Rebello S; Maignan S; Dupuy A; Mathieu M; Levell J
Bioorg Med Chem Lett; 2005 Jun; 15(11):2734-7. PubMed ID: 15911249
[TBL] [Abstract][Full Text] [Related]
3. Monocharged inhibitors of mast cell tryptase derived from potent and selective dibasic inhibitors.
Dener JM; Wang VR; Rice KD; Gangloff AR; Kuo EY; Newcomb WS; Putnam D; Wong M
Bioorg Med Chem Lett; 2001 Sep; 11(17):2325-30. PubMed ID: 11527724
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of human mast cell tryptase by benzamidine derivatives.
Stürzebecher J; Prasa D; Sommerhoff CP
Biol Chem Hoppe Seyler; 1992 Oct; 373(10):1025-30. PubMed ID: 1418674
[TBL] [Abstract][Full Text] [Related]
5. Potent selective nonpeptidic inhibitors of human lung tryptase.
Burgess LE; Newhouse BJ; Ibrahim P; Rizzi J; Kashem MA; Hartman A; Brandhuber BJ; Wright CD; Thomson DS; Vigers GP; Koch K
Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8348-52. PubMed ID: 10411878
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of selective keto-1,2,4-oxadiazole-based tryptase inhibitors.
Palmer JT; Rydzewski RM; Mendonca RV; Sperandio D; Spencer JR; Hirschbein BL; Lohman J; Beltman J; Nguyen M; Liu L
Bioorg Med Chem Lett; 2006 Jul; 16(13):3434-9. PubMed ID: 16644215
[TBL] [Abstract][Full Text] [Related]
7. Bis(5-amidino-2-benzimidazolyl)methane and related amidines are potent, reversible inhibitors of mast cell tryptases.
Caughey GH; Raymond WW; Bacci E; Lombardy RJ; Tidwell RR
J Pharmacol Exp Ther; 1993 Feb; 264(2):676-82. PubMed ID: 8437115
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of tryptase for the treatment of mast cell-mediated diseases.
Rice KD; Tanaka RD; Katz BA; Numerof RP; Moore WR
Curr Pharm Des; 1998 Oct; 4(5):381-96. PubMed ID: 10197050
[TBL] [Abstract][Full Text] [Related]
9. Novel, potent, selective, and orally bioavailable human betaII-tryptase inhibitors.
Sperandio D; Tai VW; Lohman J; Hirschbein B; Mendonca R; Lee CS; Spencer JR; Janc J; Nguyen M; Beltman J; Sprengeler P; Scheerens H; Lin T; Liu L; Gadre A; Kellogg A; Green MJ; McGrath ME
Bioorg Med Chem Lett; 2006 Aug; 16(15):4085-9. PubMed ID: 16725321
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil myeloperoxidase is a potent and selective inhibitor of mast cell tryptase.
Cregar L; Elrod KC; Putnam D; Moore WR
Arch Biochem Biophys; 1999 Jun; 366(1):125-30. PubMed ID: 10334872
[TBL] [Abstract][Full Text] [Related]
11. Design of bivalent ligands using hydrogen bond linkers: synthesis and evaluation of inhibitors for human beta-tryptase.
Vaz RJ; Gao Z; Pribish J; Chen X; Levell J; Davis L; Albert E; Brollo M; Ugolini A; Cramer DM; Cairns J; Sides K; Liu F; Kwong J; Kang J; Rebello S; Elliot M; Lim H; Chellaraj V; Singleton RW; Li Y
Bioorg Med Chem Lett; 2004 Dec; 14(24):6053-6. PubMed ID: 15546728
[TBL] [Abstract][Full Text] [Related]
12. Active site mapping of trypsin, thrombin and matriptase-2 by sulfamoyl benzamidines.
Dosa S; Stirnberg M; Lülsdorff V; Häußler D; Maurer E; Gütschow M
Bioorg Med Chem; 2012 Nov; 20(21):6489-505. PubMed ID: 23026080
[TBL] [Abstract][Full Text] [Related]
13. Structure based design of 4-(3-aminomethylphenyl)piperidinyl-1-amides: novel, potent, selective, and orally bioavailable inhibitors of betaII tryptase.
Levell J; Astles P; Eastwood P; Cairns J; Houille O; Aldous S; Merriman G; Whiteley B; Pribish J; Czekaj M; Liang G; Maignan S; Guilloteau JP; Dupuy A; Davidson J; Harrison T; Morley A; Watson S; Fenton G; McCarthy C; Romano J; Mathew R; Engers D; Gardyan M; Sides K; Kwong J; Tsay J; Rebello S; Shen L; Wang J; Luo Y; Giardino O; Lim HK; Smith K; Pauls H
Bioorg Med Chem; 2005 Apr; 13(8):2859-72. PubMed ID: 15781396
[TBL] [Abstract][Full Text] [Related]
14. Dibasic inhibitors of human mast cell tryptase. Part 1: synthesis and optimization of a novel class of inhibitors.
Rice KD; Gangloff AR; Kuo EY; Dener JM; Wang VR; Lum R; Newcomb WS; Havel C; Putnam D; Cregar L; Wong M; Warne RL
Bioorg Med Chem Lett; 2000 Oct; 10(20):2357-60. PubMed ID: 11055355
[TBL] [Abstract][Full Text] [Related]
15. Novel pyrazinone inhibitors of mast cell tryptase: synthesis and SAR evaluation.
Hopkins C; Neuenschwander K; Scotese A; Jackson S; Nieduzak T; Pauls H; Liang G; Sides K; Cramer D; Cairns J; Maignan S; Mathieu M
Bioorg Med Chem Lett; 2004 Oct; 14(19):4819-23. PubMed ID: 15341931
[TBL] [Abstract][Full Text] [Related]
16. Dibasic inhibitors of human mast cell tryptase. Part 2: structure-activity relationships and requirements for potent activity.
Rice KD; Wang VR; Gangloff AR; Kuo EY; Dener JM; Newcomb WS; Young WB; Putnam D; Cregar L; Wong M; Simpson PJ
Bioorg Med Chem Lett; 2000 Oct; 10(20):2361-6. PubMed ID: 11055356
[TBL] [Abstract][Full Text] [Related]
17. Mast cell tryptase: hoisted by its own petard?
Caughey GH
J Clin Invest; 1996 Feb; 97(4):895-6. PubMed ID: 8613539
[No Abstract] [Full Text] [Related]
18. Inhibitors of mast cell tryptase beta as therapeutics for the treatment of asthma and inflammatory disorders.
Cairns JA
Pulm Pharmacol Ther; 2005; 18(1):55-66. PubMed ID: 15607128
[TBL] [Abstract][Full Text] [Related]
19. [Modulatory effect of bisbenzamidine, a specific inhibitor of tryptase on mast cell secretion].
Xie H; He SH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan; 19(1):100-2. PubMed ID: 15132923
[TBL] [Abstract][Full Text] [Related]
20. The role of mast cell tryptase in regulating endothelial cell proliferation, cytokine release, and adhesion molecule expression: tryptase induces expression of mRNA for IL-1 beta and IL-8 and stimulates the selective release of IL-8 from human umbilical vein endothelial cells.
Compton SJ; Cairns JA; Holgate ST; Walls AF
J Immunol; 1998 Aug; 161(4):1939-46. PubMed ID: 9712064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
